Magda Esebua

646 total citations
51 papers, 435 citations indexed

About

Magda Esebua is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Magda Esebua has authored 51 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 18 papers in Pulmonary and Respiratory Medicine and 17 papers in Oncology. Recurrent topics in Magda Esebua's work include Salivary Gland Tumors Diagnosis and Treatment (12 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Head and Neck Anomalies (7 papers). Magda Esebua is often cited by papers focused on Salivary Gland Tumors Diagnosis and Treatment (12 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Head and Neck Anomalies (7 papers). Magda Esebua collaborates with scholars based in United States. Magda Esebua's co-authors include Lester J. Layfield, Robert L. Schmidt, Shellaine R. Frazier, Zhongbo Yang, Richard Hammer, Zubair Baloch, Ilker Ersoy, Benjamin L. Witt, Sharon L. Bachman and Sheila A. Grant and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and Clinical Gastroenterology and Hepatology.

In The Last Decade

Magda Esebua

46 papers receiving 431 citations

Peers

Magda Esebua
Rema Rao United States
Basim Al‐Khafaji United States
Jinhyun Choi South Korea
Karen Chau United States
Shudong Hu China
Brian Swendseid United States
Mauro Saieg Brazil
Francesca Pagliuca Italy
Chenyu Lin United States
Howard H. Wu United States
Rema Rao United States
Magda Esebua
Citations per year, relative to Magda Esebua Magda Esebua (= 1×) peers Rema Rao

Countries citing papers authored by Magda Esebua

Since Specialization
Citations

This map shows the geographic impact of Magda Esebua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magda Esebua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magda Esebua more than expected).

Fields of papers citing papers by Magda Esebua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magda Esebua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magda Esebua. The network helps show where Magda Esebua may publish in the future.

Co-authorship network of co-authors of Magda Esebua

This figure shows the co-authorship network connecting the top 25 collaborators of Magda Esebua. A scholar is included among the top collaborators of Magda Esebua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magda Esebua. Magda Esebua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Zhongbo, et al.. (2025). Molecular Testing Using ThyGeNEXT/ThyraMIR in Thyroid Nodules With Indeterminate Cytology: A Single Medical Institute Experience. Diagnostic Cytopathology. 53(7). 351–356. 2 indexed citations
2.
Zhang, Xiaoming, Magda Esebua, & Lester J. Layfield. (2025). American College of Radiology Thyroid Imaging Reporting System and cytopathologic classification: integration for improved assessment of malignancy risk. Journal of the American Society of Cytopathology. 15(1). 73–78.
3.
Esebua, Magda, et al.. (2024). Osimertinib Resistance via Histologic Transformation From Non-small Cell Lung Carcinoma to Carcinosarcoma. Cureus. 16(4). e59293–e59293. 1 indexed citations
4.
Layfield, Lester J., et al.. (2024). World Health Organization Reporting System for Soft Tissue Cytopathology: Risk of malignancy and reproducibility of categories among observers. Diagnostic Cytopathology. 52(9). 480–484. 4 indexed citations
5.
Esebua, Magda, et al.. (2023). Impact of Imaging and Clinical Diagnoses on Accuracy of Cytologic Diagnosis of Pulmonary Nodules. Journal of the American Society of Cytopathology. 12(5). S37–S37. 1 indexed citations
6.
Esebua, Magda, et al.. (2023). Diagnosis of salivary gland tumors: Does the triple diagnosis method have value?. Diagnostic Cytopathology. 51(9). 527–531. 1 indexed citations
7.
Layfield, Lester J., Tao Zhang, & Magda Esebua. (2022). PD‐L1 immunohistochemical testing: A review with reference to cytology specimens. Diagnostic Cytopathology. 51(1). 51–58. 4 indexed citations
8.
Yang, Zhongbo, Tao Zhang, Lester J. Layfield, & Magda Esebua. (2021). Performance of Afirma Gene Sequencing Classifier versus Gene Expression Classifier in thyroid nodules with indeterminate cytology. Journal of the American Society of Cytopathology. 11(2). 74–78. 13 indexed citations
9.
Layfield, Lester J., Tao Zhang, Magda Esebua, & Robert L. Schmidt. (2021). Atypia in pulmonary cytology: A cytomorphometric analysis of the spectrum of changes between benign and malignant. Diagnostic Cytopathology. 49(8). 909–914. 2 indexed citations
10.
Dodd, Leslie G., et al.. (2021). PD-L1 expression in sarcomas: An immunohistochemical study and review of the literature. Annals of Diagnostic Pathology. 55. 151823–151823. 6 indexed citations
11.
Layfield, Lester J., Guoliang Wang, Zhongbo Yang, et al.. (2020). Interobserver Agreement for the International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology. Acta Cytologica. 64(5). 413–419. 10 indexed citations
12.
Hammoud, Ghassan M., et al.. (2019). A rare case of plexiform fibromyxoma in stomach: FNA diagnosis with histological correlation and differential diagnoses. Annals of Diagnostic Pathology. 44. 151453–151453. 6 indexed citations
13.
14.
Kumar, Senthil R., et al.. (2017). Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma. BMC Cancer. 17(1). 158–158. 17 indexed citations
15.
Layfield, Lester J., et al.. (2017). Impact of Consensus Conference Review on Diagnostic Disagreements in the Evaluation of Cervical Biopsy Specimens. American Journal of Clinical Pathology. 147(5). 473–476. 4 indexed citations
16.
17.
Layfield, Lester J., Shellaine R. Frazier, Magda Esebua, & Robert L. Schmidt. (2016). Interobserver reproducibility for HER2/neu immunohistochemistry: A comparison of reproducibility for the HercepTest™ and the 4B5 antibody clone. Pathology - Research and Practice. 212(3). 190–195. 20 indexed citations
18.
Layfield, Lester J., Magda Esebua, Robert L. Schmidt, & Benjamin L. Witt. (2015). Malignancy risk associated with the EBUS-FNA diagnostic categories nondiagnostic, benign, atypical, suspicious for malignancy, and malignant for mediastinal lymph node aspirate specimens. Journal of the American Society of Cytopathology. 4(5). 276–281. 2 indexed citations
19.
Deeken, Corey R., Magda Esebua, Sharon L. Bachman, Bruce Ramshaw, & Sheila A. Grant. (2011). Assessment of the biocompatibility of two novel, bionanocomposite scaffolds in a rodent model. Journal of Biomedical Materials Research Part B Applied Biomaterials. 96B(2). 351–359. 24 indexed citations
20.
Templer, Jerry W., et al.. (2009). Episodic painful parotid swelling caused by sialodochitis with eosinophilic inflammation: A new entity. Otolaryngology. 140(1). 132–133. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rema Rao Breakdown of academic impact, for papers by Basim Al‐Khafaji Breakdown of academic impact, for papers by Jinhyun Choi Breakdown of academic impact, for papers by Karen Chau Breakdown of academic impact, for papers by Shudong Hu Breakdown of academic impact, for papers by Brian Swendseid Breakdown of academic impact, for papers by Mauro Saieg Breakdown of academic impact, for papers by Francesca Pagliuca Breakdown of academic impact, for papers by Chenyu Lin Breakdown of academic impact, for papers by Howard H. Wu
Rankless by CCL
2026